Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 04:06:00 UTC
Update Date2021-09-26 23:00:33 UTC
HMDB IDHMDB0249583
Secondary Accession NumbersNone
Metabolite Identification
Common NameCanertinib
DescriptionCanertinib, also known as CI-1033, belongs to the class of organic compounds known as quinazolinamines. These are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups. Based on a literature review very few articles have been published on Canertinib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Canertinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Canertinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
CI-1033ChEBI
CanertinibMeSH
Chemical FormulaC24H25ClFN5O3
Average Molecular Weight485.938
Monoisotopic Molecular Weight485.162995603
IUPAC NameN-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide
Traditional Namecanertinib
CAS Registry NumberNot Available
SMILES
FC1=C(Cl)C=C(NC2=NC=NC3=CC(OCCCN4CCOCC4)=C(NC(=O)C=C)C=C23)C=C1
InChI Identifier
InChI=1S/C24H25ClFN5O3/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29)
InChI KeyOMZCMEYTWSXEPZ-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as quinazolinamines. These are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassDiazanaphthalenes
Sub ClassBenzodiazines
Direct ParentQuinazolinamines
Alternative Parents
Substituents
  • Quinazolinamine
  • N-arylamide
  • Aniline or substituted anilines
  • Alkyl aryl ether
  • Halobenzene
  • Fluorobenzene
  • Aminopyrimidine
  • Chlorobenzene
  • Pyrimidine
  • Aryl chloride
  • Imidolactam
  • Benzenoid
  • Morpholine
  • Oxazinane
  • Monocyclic benzene moiety
  • Aryl halide
  • Aryl fluoride
  • Heteroaromatic compound
  • Acrylic acid or derivatives
  • Amino acid or derivatives
  • Carboxamide group
  • Tertiary aliphatic amine
  • Tertiary amine
  • Secondary carboxylic acid amide
  • Secondary amine
  • Oxacycle
  • Carboxylic acid derivative
  • Azacycle
  • Ether
  • Dialkyl ether
  • Organohalogen compound
  • Organic nitrogen compound
  • Organic oxygen compound
  • Amine
  • Carbonyl group
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organochloride
  • Organofluoride
  • Organonitrogen compound
  • Organooxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP4.09ALOGPS
logP3.9ChemAxon
logS-4.5ALOGPS
pKa (Strongest Acidic)12.54ChemAxon
pKa (Strongest Basic)6.87ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area88.61 ŲChemAxon
Rotatable Bond Count9ChemAxon
Refractivity130.55 m³·mol⁻¹ChemAxon
Polarizability50.36 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M-2H]-242.51730932474
DeepCCS[M+Na]+217.8130932474
AllCCS[M+H]+211.032859911
AllCCS[M+H-H2O]+209.132859911
AllCCS[M+NH4]+212.732859911
AllCCS[M+Na]+213.232859911
AllCCS[M-H]-204.032859911
AllCCS[M+Na-2H]-204.432859911
AllCCS[M+HCOO]-205.032859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
CanertinibFC1=C(Cl)C=C(NC2=NC=NC3=CC(OCCCN4CCOCC4)=C(NC(=O)C=C)C=C23)C=C15380.7Standard polar33892256
CanertinibFC1=C(Cl)C=C(NC2=NC=NC3=CC(OCCCN4CCOCC4)=C(NC(=O)C=C)C=C23)C=C13815.1Standard non polar33892256
CanertinibFC1=C(Cl)C=C(NC2=NC=NC3=CC(OCCCN4CCOCC4)=C(NC(=O)C=C)C=C23)C=C14512.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Canertinib,1TMS,isomer #1C=CC(=O)NC1=CC2=C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C)N=CN=C2C=C1OCCCN1CCOCC14026.4Semi standard non polar33892256
Canertinib,1TMS,isomer #1C=CC(=O)NC1=CC2=C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C)N=CN=C2C=C1OCCCN1CCOCC13640.8Standard non polar33892256
Canertinib,1TMS,isomer #1C=CC(=O)NC1=CC2=C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C)N=CN=C2C=C1OCCCN1CCOCC15518.9Standard polar33892256
Canertinib,1TMS,isomer #2C=CC(=O)N(C1=CC2=C(NC3=CC=C(F)C(Cl)=C3)N=CN=C2C=C1OCCCN1CCOCC1)[Si](C)(C)C3938.0Semi standard non polar33892256
Canertinib,1TMS,isomer #2C=CC(=O)N(C1=CC2=C(NC3=CC=C(F)C(Cl)=C3)N=CN=C2C=C1OCCCN1CCOCC1)[Si](C)(C)C3584.3Standard non polar33892256
Canertinib,1TMS,isomer #2C=CC(=O)N(C1=CC2=C(NC3=CC=C(F)C(Cl)=C3)N=CN=C2C=C1OCCCN1CCOCC1)[Si](C)(C)C5624.4Standard polar33892256
Canertinib,2TMS,isomer #1C=CC(=O)N(C1=CC2=C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C)N=CN=C2C=C1OCCCN1CCOCC1)[Si](C)(C)C3775.9Semi standard non polar33892256
Canertinib,2TMS,isomer #1C=CC(=O)N(C1=CC2=C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C)N=CN=C2C=C1OCCCN1CCOCC1)[Si](C)(C)C3466.3Standard non polar33892256
Canertinib,2TMS,isomer #1C=CC(=O)N(C1=CC2=C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C)N=CN=C2C=C1OCCCN1CCOCC1)[Si](C)(C)C5025.3Standard polar33892256
Canertinib,1TBDMS,isomer #1C=CC(=O)NC1=CC2=C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C(C)(C)C)N=CN=C2C=C1OCCCN1CCOCC14218.4Semi standard non polar33892256
Canertinib,1TBDMS,isomer #1C=CC(=O)NC1=CC2=C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C(C)(C)C)N=CN=C2C=C1OCCCN1CCOCC13794.0Standard non polar33892256
Canertinib,1TBDMS,isomer #1C=CC(=O)NC1=CC2=C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C(C)(C)C)N=CN=C2C=C1OCCCN1CCOCC15481.4Standard polar33892256
Canertinib,1TBDMS,isomer #2C=CC(=O)N(C1=CC2=C(NC3=CC=C(F)C(Cl)=C3)N=CN=C2C=C1OCCCN1CCOCC1)[Si](C)(C)C(C)(C)C4134.4Semi standard non polar33892256
Canertinib,1TBDMS,isomer #2C=CC(=O)N(C1=CC2=C(NC3=CC=C(F)C(Cl)=C3)N=CN=C2C=C1OCCCN1CCOCC1)[Si](C)(C)C(C)(C)C3775.4Standard non polar33892256
Canertinib,1TBDMS,isomer #2C=CC(=O)N(C1=CC2=C(NC3=CC=C(F)C(Cl)=C3)N=CN=C2C=C1OCCCN1CCOCC1)[Si](C)(C)C(C)(C)C5584.2Standard polar33892256
Canertinib,2TBDMS,isomer #1C=CC(=O)N(C1=CC2=C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C(C)(C)C)N=CN=C2C=C1OCCCN1CCOCC1)[Si](C)(C)C(C)(C)C4147.8Semi standard non polar33892256
Canertinib,2TBDMS,isomer #1C=CC(=O)N(C1=CC2=C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C(C)(C)C)N=CN=C2C=C1OCCCN1CCOCC1)[Si](C)(C)C(C)(C)C3779.3Standard non polar33892256
Canertinib,2TBDMS,isomer #1C=CC(=O)N(C1=CC2=C(N(C3=CC=C(F)C(Cl)=C3)[Si](C)(C)C(C)(C)C)N=CN=C2C=C1OCCCN1CCOCC1)[Si](C)(C)C(C)(C)C4991.8Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Canertinib GC-MS (Non-derivatized) - 70eV, Positivesplash10-0zfr-9305500000-42b0ec2c269a58f9e7f22021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Canertinib GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Canertinib 10V, Positive-QTOFsplash10-001r-0101900000-9bc88a73c10df6bd02742016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Canertinib 20V, Positive-QTOFsplash10-0ue9-4905700000-6a2b9e59d45824ffac262016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Canertinib 40V, Positive-QTOFsplash10-0f9l-8965000000-9ed9a5902ba5708bb5c02016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Canertinib 10V, Negative-QTOFsplash10-053r-2103900000-4a44b2d4d4e47679dd4b2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Canertinib 20V, Negative-QTOFsplash10-0pc9-7109400000-bf1dd09ef0b9ba0d28dc2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Canertinib 40V, Negative-QTOFsplash10-0fk9-7398000000-78462c2dd1330e8d00c92016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Canertinib 10V, Positive-QTOFsplash10-000i-0000900000-357edfc8c1369d8b36662021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Canertinib 20V, Positive-QTOFsplash10-000i-0101900000-e404117d2ec78afffac72021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Canertinib 40V, Positive-QTOFsplash10-0udl-2309500000-867765aafe00e13d9b732021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Canertinib 10V, Negative-QTOFsplash10-001i-0000900000-4082b100d8f4ad7cd1432021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Canertinib 20V, Negative-QTOFsplash10-001i-0006900000-1d1d07987279e29739fc2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Canertinib 40V, Negative-QTOFsplash10-0ziu-3019200000-830f0e86cfbae7d3e09c2021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB05424
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID137741
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkCanertinib
METLIN IDNot Available
PubChem Compound156414
PDB IDNot Available
ChEBI ID61399
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]